4-methoxyamphetamine has been researched along with endothelin-1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carayon, A; Escolano, S; Isnard, R; Kalotka, H; Komajda, M; Lechat, P; Maistre, G; Pousset, F; Thomas, D | 1 |
| Braunwald, E; de Lemos, JA; Jarolim, P; Morrow, DA; Omland, T; Pfeffer, MA; Sabatine, MS; Sloan, S; Solomon, SD | 1 |
1 trial(s) available for 4-methoxyamphetamine and endothelin-1
| Article | Year |
|---|---|
Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease.
Topics: Adrenomedullin; Aged; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Biomarkers; Cardiovascular Diseases; Coronary Disease; Death; Endothelin-1; Female; Glycopeptides; Heart Failure; Humans; Indoles; Male; Middle Aged; Peptide Fragments; Prognosis; Protein Precursors; Risk; Stress, Physiological; Stroke Volume | 2012 |
1 other study(ies) available for 4-methoxyamphetamine and endothelin-1
| Article | Year |
|---|---|
Prognostic value of plasma endothelin-1 in patients with chronic heart failure.
Topics: Atrial Natriuretic Factor; Biomarkers; Chronic Disease; Death; Echocardiography; Endothelin-1; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Norepinephrine; Prognosis; Radioimmunoassay; Survival Rate | 1997 |